|
||||
more information »
 |
Over the years, the Samuel Waxman Cancer Research Foundation has supported
and trained more than 150 scientists by awarding over $50 million in grants,
and has been instrumental in developing new drugs to successfully treat
cancer. Based at The Mount Sinai Medical Center in New York City, one of the
world's preeminent teaching hospitals, the Foundation funds highly
collaborative basic, translational and clinical research groups throughout
the United States, Canada, China, Israel and Europe.
The Samuel Waxman Cancer Research Foundation is unique in that its research
is not disease-specific but concept driven. The Foundation has already
proven that non-toxic differentiation therapy is a powerful way to treat
leukemia, having discovered two drugs that are now used worldwide. The
Foundation's investigators are considered leaders in the study of
differentiation and publish their findings in many major scientific journals
in the United States and abroad.
It is the Foundation's hope that the groundbreaking work conducted with its
support will lead to site-specific treatments for all cancers, and will
ultimately contribute to the prevention and cure of the disease by blocking
the spread of cancer.
To learn more about the Samuel Waxman Cancer Research Foundation go to:
http://www.waxmancancer.org
Samuel Waxman Cancer Research Foundation Newsletter Spring 2006
http://www.waxmancancer.org/pdf/newsletter_sp_06.pdf
